Introduction
Currently, alcohol abuse is a significant worldwide problem not only for individuals but also for society. The substantial morbidity and mortality associated with alcohol abuse has encouraged scientists to develop effective methods for postponing or preventing the pathogenesis that results from ethanol exposure (Holmes et al. 2014 ).
Many studies indicate that ethanol metabolism can interrupt the mitochondrial redox balance that protects against reactive oxygen species (ROS). ROS have also been associated with inflammation and cell death in ethanol-induced liver injury. Therefore, designing a therapy to ameliorate ROS could be an important strategy for the treatment of ethanol-induced liver disease.
Rosmarinus officinalis L is an herb that is widely used as a folk medicine, in cosmetics and as a flavoring agent worldwide. A major compound of R. officinalis is carnosic acid (CA). CA has many pharmaceutical characteristics, such as antioxidative, anti-inflammatory and anti-adipogenic activities (Wang et al. 2012 ). D r a f t 4 Alcohol abuse radically increases mitochondrial ROS production, overcoming the antioxidant defense system and leading to the pathogenesis of a number of human diseases. The impact of ROS and subsequent apoptosis can be inhibited, at least in part, by sirtuin 1 (SIRT1). SIRT1, a NAD-dependent class III histone deacetylase (HDAC), has been implicated in the regulation of genomic stability, cellular stress resistance, and senescence via the deacetylation of its target proteins (Vaziri et al. 2001) . SIRT1 is the best-characterized target of ethanol in the liver, and it plays a significant role in alcoholic liver disease (Li et al. 2014; Yin et al. 2014 ).
The p66Shc protein belongs to a family of proteins that control cellular stress response and longevity, and it has been the topic of an emerging field of study: signal transmission by ROS. In response to pro-oxidant stimuli, p66Shc promotes the formation of ROS in mitochondria and stimulates apoptotic cell death. Among the potential mechanisms of alcohol-induced liver injury, p66Shc and ROS signaling appear to be challenging targets for specific modulation but useful for developing mitochondria-targeted therapeutics (Koch et al. 2008) . Interestingly, we and others have recently reported that the inhibition of p66Shc expression by SIRT1 protects against hyperglycemia-induced endothelial damage and liver ischemia-reperfusion injury (Yan et al. 2014; Zhou et al. 2011) . However, whether SIRT1-mediated p66Shc inhibition is implicated in acute alcoholic liver injury and by what exact mechanism this may occur are both currently unknown. According to the aims of this study, we considered the potential roles of cytochrome C and apoptosis-inducing factor (AIF) in these processes, as they are related to ethanol-induced mitochondrial dysfunction (X. D r a f t 5 Zhang et al. 2010) . This study aimed to evaluate the protective role of CA against ethanol-induced liver injury via a SIRT1/p66Shc-mediated mitochondrial pathway.
Materials and methods

Reagents
Carnosic acid (CA), purchased from Shanghai Winherb Medical Science Co., Ltd (Shanghai, China), was dissolved in olive oil for animal studies and in DMSO for cell culture experiments. Ethanol (purity >99%) was obtained from Sigma Co., Ltd (Sigma, USA).
Animal model
Male Wistar rats with weights ranging from 180 to 220 g were obtained from the Animal Center of Dalian Medical University (Dalian, China). The rats were housed under standard laboratory conditions for one week prior to experimentation. The experiments were performed in accordance with the institutional guidelines for the care and use of laboratory animals and were approved by the Committee on the Ethics of Animal Experiments of Dalian Medical University (Dalian, China).
The rats were pretreated with CA intragastrically (20 mg/kg, 40 mg/kg) once a day for three days. Ethanol, at a dose of 6 g/kg, was also administered intragastrically to the rats every 12 hours at 3 different time points to induce acute liver injury. The dosages of CA were determined in preliminary experiments. Rats in the control group were given an equal volume of olive oil as a vehicle control. Ten hours after the last alcohol D r a f t 6 treatment, the rats were euthanized, and liver and blood samples were collected for further assays.
Biochemical assays
Levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined according to the manufacturer's instructions, as were levels of glutathione (GSH), glutathione peroxidase (GSH-PX) and malondialdehyde (MDA) in the liver. All of the assay kits used were purchased from Nanjing Jiangcheng Bioengineering Institute (Nanjing, China).
Liver histological examination
The middle lobe of the right liver of each rat was excised for histopathological examination. The liver samples were fixed in 4% neutral buffered formalin for 24 h, embedded in paraffin, sliced into 5-µm sections, stained with hematoxylin and eosin (H&E) and evaluated by examination with a light microscope.
Cell culture and cell viability assay Human hepatic L02 cells were cultured in RPMI-1640 medium with 10% fetal bovine serum, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10 mg/mL insulin. The cells were kept at 37°C in a humidified atmosphere of air and 5% CO 2 . The protocol for each experiment is described in the corresponding figure legend. Cell viability and survival were determined using an MTT (Sigma) assay. After treatment, the cultures were incubated with an MTT solution (5 mg/ml) for 4 h at 37°C. The medium was then discarded, and formazan crystals were dissolved by the addition of 100 µl of dimethyl sulfoxide. The absorbance at 570 nm was measured using an enzyme-linked immunosorbent assay microplate reader (Thermo, France).
Cell viability was defined relative to an untreated control.
RNA Interference
The small interfering RNA (siRNA) sequences used to target SIRT1 are as follows:
5'-UUCUGAAAGCUUUACAGGGdtdt-3'. Both specific and control siRNAs were obtained from GenePharma (Shanghai, China). After siRNA transfection for 48 hours, the cells were treated with 10 µM CA for an additional 6 hours. The cells were then collected for protein analysis.
Measurement of mitochondrial membrane integrity
Mitochondrial function was measured using a JC-1 membrane potential detection kit 
Statistical analysis
All data were analyzed using SPSS 19.0 software. The results are expressed as the mean ± standard deviation (SD), and P < 0.05 was considered statistically significant.
The data were analyzed with a two-tailed unpaired Student's t-test or by one-way analysis of variance (ANOVA) to determine statistical significance between groups.
D r a f t
Results
Protective effect of CA against acute ethanol-induced liver injury
We first explored whether CA could protect rats from acute ethanol-induced hepatotoxicity. As shown in Fig. 1A and Fig. 1B , ethanol administration caused hepatotoxicity in rats, as indicated by increased serum ALT and AST levels. However, CA treatment significantly inhibited ethanol-induced ALT and AST activity in a dose-dependent manner, suggesting CA protects against ethanol-induced hepatotoxicity.
The protective effect of CA was further verified by histopathological analysis (Fig.   1C ). The tissues of rats exposed to ethanol displayed increased cellular size, nuclear pleomorphism, cytoplasmic dissolution, apoptosis and accumulation of lipid droplets, which correlated with elevated serum levels of liver enzymes. In contrast, CA pretreatment dramatically reduced ethanol-induced liver damage. The cytoprotective effect of CA in vitro was then examined in an ethanol-treated L02 cell model. The exposure of L02 cells to ethanol resulted in a significant reduction of cell viability (Fig. 1D) . Pretreatment of the cells with CA, however, attenuated the ethanol effect on cell viability in a dose-dependent manner. Thus, these results indicated that CA effectively protects against binge ethanol-induced liver injury.
Effect of CA on antioxidative activity during ethanol-induced hepatotoxicity Ethanol metabolism generates ROS and causes lipid peroxidation, resulting in mitochondrial GSH depletion. These effects subsequently prime and sensitize D r a f t 11 hepatocytes to injury, which may eventually lead to hepatocyte apoptosis (Farfan Labonne et al. 2009; Setshedi et al. 2010) . As shown in Fig. 2 , binge ethanol-induced liver injury in rats caused a significant decrease in liver GSH and GSH-PX levels and a large increase in liver MDA levels compared with the control group. However, after pretreatment with CA, liver GSH and GSH-PX activity apparently increased, while liver MDA levels decreased.
CA-mediated protection against ethanol-induced hepatotoxicity associated with SIRT1 upregulation SIRT1 activation has been shown to inhibit apoptosis and inflammation and to protect against oxidative stress, thereby improving acute and chronic liver injuries (Li et al. 2014; Yan et al. 2014; Yin et al. 2014) . Hence, we investigated whether CA-mediated protection involves SIRT1 upregulation. As shown in Fig. 3A , after the administration of ethanol, hepatic SIRT1 protein levels were reduced in comparison to those of the control group. In contrast, CA pretreatment enhanced the expression of SIRT1 protein relative to the ethanol-only group in a dose-dependent manner. The level of SIRT1 mRNA was consistent with the level of SIRT1 protein expression (Fig. 3C) . Thus, it appeared that SIRT1 activation was associated with CA-mediated protection against binge ethanol-induced hepatotoxicity.
Next, we used L02 cells to further confirm that CA treatment causes SIRT1 upregulation in vitro. In accordance with the in vivo results, SIRT1 protein levels in the ethanol group increased after a 10-µM CA pretreatment (Fig. 3B) . However, the D r a f t activating effect of CA on SIRT1 was abolished when SIRT1 was inhibited by EX527, a specific SIRT1 inhibitor. We also examined SIRT1mRNA expression in vitro. CA pretreatment increased SIRT1 mRNA expression in response to ethanol exposure (Fig.3D) . Whereas, the EX527 did not suppress SIRT1 mRNA expression, which is consistent with the results in HEK293 cells reported previously (Wu et al. 2012 ).
Together, these results suggested that CA-mediated protection against ethanol-induced hepatotoxicity involves SIRT1 upregulation.
SIRT1 upregulation by CA inhibited p66Shc activation during binge ethanol-induced liver injury SIRT1 and p66Shc have been implicated in ethanol-induced liver injury, having effects on lipid metabolism, ROS production, inflammation and apoptosis (Koch et al.
2008
; Yin et al. 2014; Yin et al. 2012) . Moreover, recent research has revealed that SIRT1-mediated inhibition of p66Shc expression protects against hyperglycemia-induced endothelial damage and liver ischemia-reperfusion injury (Yan et al. 2014; Zhou et al. 2011) . Therefore, we aimed to determine whether SIRT1-mediated p66Shc inhibition was involved in binge alcohol-induced liver injury.
As expected, p66Shc protein levels in the liver were significantly increased in the ethanol group compared to the control group. However, CA pretreatment effectively repressed p66Shc protein expression in a dose-dependent manner (Fig. 4A) . To assess whether ethanol increases mitochondrial translocation of p66Shc, the presence of p66Shc in mitochondrial lysates was assessed by western blotting. As shown in In vitro studies were used to further explore the role of SIRT1 in regulating p66Shc during ethanol-induced hepatotoxicity. The results showed that the inhibition of SIRT1 by EX527 resulted in increased p66Shc expression and mitochondrial translocation in L02 cells after ethanol exposure (Fig. 4B) . Moreover, CA-induced downregulation of p66Shc expression and mitochondrial translocation was attenuated by SIRT1 knockdown. Together, these results indicated that SIRT1-mediated p66Shc
inhibition plays a role in binge alcohol-induced liver injury and that the protective effects of CA against alcohol-induced liver injury may be related to this mechanism.
CA alleviated binge ethanol-induced mitochondrial injury
In mitochondria, p66Shc oxidizes cytochrome C to generate ROS, which induce the opening of the mitochondrial permeability transition pore, thereby facilitating the release of cytochrome C and H 2 O 2 into the cytosol (Giorgio et al. 2005) . Thus, western blot analysis was used to assess isolated mitochondrial and cytosolic fractions to identify the subcellular localizations of proteins involved in the mitochondria-mediated apoptotic signaling pathway. In the liver, ethanol exposure caused a significant release of cytochrome C from mitochondria into the cytosol. In contrast, accompanying SIRT1-mediated p66Shc inhibition, CA pretreatment substantially restored the mitochondrial localization of cytochrome C (Fig. 5A) . To D r a f t 14 further verify this observation, we examined cytochrome C release in vitro (Fig. 5B) .
After ethanol treatment, CA-treated cells showed a decrease in the release of cytochrome C; however, cells treated with EX527 showed a clear increase in the release of cytochrome C from mitochondria. Furthermore, EX527 significantly attenuated CA-mediated inhibition of cytochrome C release. These results indicated that the protective effects of CA against ethanol-induced liver injury may be related to decreased release of cytochrome C. Mitochondrial damage can also release AIF, another important mitochondrial protein. AIF released from mitochondria is subsequently translocated to the nucleus; this pathway is a typical feature of apoptotic death (Cherian et al. 2008) . As with cytochrome C, AIF was released from mitochondria into the nucleus after ethanol treatment (Fig. 5C ). Moreover, AIF release could be reduced by CA or aggravated by EX527 (Fig. 5D ).
Ethanol not only triggers mitochondrial superoxide production but also disrupts the mitochondrial membrane (Xu et al. 2015) . Therefore, JC-1 staining, a method of assessing mitochondrial damage, was used in vitro (Fig. 5E ). As expected, ethanol caused a significant loss of JC-1 red fluorescence and led to increased green fluorescence relative to the control, indicating apoptosis in the mitochondria; however, CA treatment nearly completely reversed these changes. In contrast, EX527 markedly attenuated CA-mediated inhibition of these mitochondrial membrane changes.
Collectively, these findings suggest that CA alleviates binge ethanol-induced injury, which may partially depend on a SIRT1/p66Shc-mediated mitochondrial pathway.
To further investigate the effects of SIRT1/p66Shc on mitochondria during ethanol D r a f t 15 exposure, SIRT1 was silenced using siRNA (si-SIRT1). si-SIRT1 increased both p66Shc expression and the release of cytochrome-c and AIF from mitochondria ( Fig.   6 ). In addition, si-SIRT1 abolished the inhibition of p66Shc expression and the release of cytochrome-c and AIF caused by treatment with CA. Taken together, these results demonstrate that CA protects against ethanol-induced mitochondrial injury in a process that involves SIRT1-mediated p66Shc inhibition.
Discussion
Alcohol abuse is a worldwide public health issue. The molecular mechanisms underlying acute ethanol hepatotoxicity are still debated. Therefore, further information is urgently needed to identify novel preventive and therapeutic opportunities. The present work showed that SIRT1/p66Shc is a key therapeutic target for preventing binge ethanol-induced liver injury and that CA effectively protects against this injury type, which may be associated with a SIRT1/p66Shc-mediated mitochondrial pathway.
Rosemary is a plant that is widely utilized in the food industry for its functional properties and beneficial health properties. CA exhibits a range of pharmaceutical properties, including antioxidant, anti-inflammatory and anti-apoptotic effects (Wang et al. 2011; Wang et al. 2012) . In the present study, we explored the protective role of CA against binge ethanol-induced liver injury. We found that serum transaminase activity markedly increased following acute alcohol intoxication. In parallel with this effect, enhanced lipid peroxidation and decreased GSH and GSH-PX levels were 
2014
; Yin et al. 2012) . In support of these observations, we found that SIRT1 expression in the liver significantly decreased in rats acutely exposed to alcohol.
However, CA enhanced SIRT1 expression, indicating that CA might protect rats from acute alcohol-induced liver injury via SIRT1 upregulation. This idea was further confirmed by SIRT1 inhibition in L02 cells. In ethanol-exposed cells, CA pretreatment increased SIRT1 expression; however, specific inhibition of SIRT1 by EX527 or si-SIRT1 attenuated this upregulation, indicating that CA's effects on SIRT1 provide protection against acute ethanol-induced liver injury.
A previous study indicated that p66Shc is a potential molecular mediator of the deleterious effects of alcohol on cell metabolism and viability and that it plays a vital role in mitochondrial damage in alcohol-dependent pathologies. In our study, p66Shc expression significantly increased following ethanol exposure, while CA pretreatment D r a f t caused it to dose-dependently decrease. Furthermore, p66Shc underwent mitochondrial translocation following ethanol exposure, which was restrained by CA.
This result indicated that the protection against ethanol-induced liver injury afforded by CA treatment involved its inhibitory effect on p66Shc. A growing body of evidence has implied that SIRT1 is crucial for repressing p66Shc transcription (Yan et al. 2014; Zhou et al. 2011) . Zhou et al. demonstrated that SIRT1 binds to the p66Shc promoter (508 bp to 250 bp), resulting in decreased acetylation of p66Shc
promoter-bound histone H3. As a result, SIRT1 overexpression was found to decrease high glucose-induced p66Shc expression in human umbilical vein endothelial cells, an effect that was accompanied by reduced oxidative stress and improved endothelial function (Zhou et al. 2011) . Consistent with this observation, our study demonstrated that variations in p66Shc expression were opposite to those in SIRT1 expression, indicating that SIRT1 may inhibit p66Shc expression upon ethanol exposure. In vitro experiments with EX527 and si-SIRT1 provided further evidence to support this argument. In cells, the inhibition of SIRT1 by EX527 or si-SIRT1 induced p66Shc expression and attenuated the inhibition of p66Shc expression caused by CA (Fig. 4) .
Together, these observations demonstrated that CA-mediated inhibition of p66Shc occurs at least partially through the upregulation of SIRT1 expression during acute ethanol-induced liver injury.
Cytochrome C and AIF are pro-apoptotic proteins that are normally restricted to the mitochondria, and their release during the apoptotic cascade has been demonstrated (Gustafsson and Gottlieb 2008; Phaneuf and Leeuwenburgh 2002; Susin et al. 1999) .
Cytochrome C is released into the cytosol, where it triggers caspase-3 activation during oxidization, resulting in apoptosis (Giorgio et al. 2005; Kluck et al. 1997; Seo et al. 2013) . Similarly, the translocation of AIF, a 67-kD flavoprotein, from the mitochondria to the nucleus results in a "caspase-independent" pathway for programmed cell death (Cherian et al. 2008; Yu et al. 2006) . Importantly, mutations in p66Shc impair its ability to mediate apoptosis by suppressing its interaction with mitochondrial cytochrome C (Giorgio et al. 2005) . Conversely, an absence of SIRT1 leads to AIF-mediated cell death (Kolthur-Seetharam et al. 2006) . In the present study, we estimated the release and accumulation of the mitochondrial proteins cytochrome C and AIF into the cytosol. Our study revealed that CA pretreatment significantly inhibited the release of cytochrome C and AIF from liver mitochondria after ethanol exposure. In contrast, CA-induced inhibition of cytochrome C and AIF release from mitochondria was blocked when SIRT1 was inhibited by EX527 or si-SIRT1.
Meanwhile, JC-1 analysis of mitochondrial membrane integrity showed that mitochondrial injury in L02 cells was attenuated by CA but aggravated by EX527.
Together with data suggesting that disturbances in mitochondrial membrane integrity are essential for ethanol-induced cell death, the present data suggest that a CA-responsive SIRT1/p66Shc pathway has the potential to ameliorate ethanol-induced mitochondrial oxidative stress, leading to a subsequent decrease in pathological damage (Adachi and Ishii 2002; Koch et al. 2004; P. Zhang et al. 2015) .
In summary, we demonstrated for the first time that CA protects the liver from binge ethanol-induced liver injury through a SIRT1/p66Shc-mediated mitochondrial Results are expressed as the mean ± SD (n = 6). L02 cells were treated with or without 10 µM EX527 for 6 h, were incubated with 10 µM CA for 6 h, and were then exposed to 100 mM ethanol for 24 h. 
